Serum biochemical markers accurately predict liver fibrosis in hiv and hepatitis c virus co-infected patients

AIDS

Volumn 17, Issue 5, 2003, Pages 721-725

  Myers, Robert P ^a   Benhamou, Yves ^a   Imbert Bismut, Françoise ^a   Thibault, Vincent ^a   Bochet, Marie ^a   Charlotte, Frédéric ^a   Ratziu, Vlad ^a   Bricaire, François ^a   Katlama, Christine ^a   Poynard, Thierry ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Biopsy; CD4 cell count; Diagnosis; Fibrosis; Hepatitis C; HIV; Viral load

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; BILIRUBIN; BIOCHEMICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; VIRUS RNA;

ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; VIRUS LOAD;

ADULT; ALPHA-MACROGLOBULINS; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; VIRAL LOAD;

EID: 0037471273     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200303280-00010     Document Type: Article

References (26)

1. Rumi MG, Colombo M, Gringeri A, Mannucci PM. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels. Ann Intern Med 1990, 112:379-380.
2. Sherman KE, Freeman S, Harrison S, Andron L. Prevalence of antibody to hepatitis C virus in patients infected with the human immunodeficiency virus. J Infect Dis 1991, 163:414-415.
3. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999, 30:1054-1058.
4. Benhamou Y, Di Martino V, Bochet M, Colombet G, Thibault V, Liou A, et al. Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology 2001, 34: 283-287.
5. Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, et al. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. AIDS 2002, 16:813-828.
6. EASL International Consensus Conference on Hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol 1999, 31:3-8.
7. Perrillo RP. The role of liver biopsy in hepatitis C. Hepatology 1997, 26 (3 Suppl. 1):57S-61S.
8. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990, 99:1396-1400.
9. Perrault J, McGill DB, Ott BJ, Taylor WF. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978, 74:103-106.
10. Garcia-Ordonez MA, Colmenero JD, Jimenez-Onate F, Martos F, Martinez J, Juarez C. Diagnostic usefulness of percutaneous liver biopsy in HIV-infected patients with fever of unknown origin. J Infect 1999, 38:94-98.
11. Ehmann WC, Rabkin CS, Eyster ME, Goedert JJ. Thrombocytopenia in HIV-infected and uninfected hemophiliacs. Multicenter Hemophilia Cohort Study. Am J Hematol 1997, 54:296-300.
12. Churchill DR, Mann D, Coker RJ, Miller RF, Glazer G, Goldin RD, et al. Fatal haemorrhage following liver biopsy in patients with HIV infection. Genitourin Med 1996, 72:62-64.
13. Friedman SL, Maher JJ, Bissell DM. Mechanisms and therapy of hepatic fibrosis. Report of the AASLD Single Topic Basic Research Conference. Hepatology 2000, 32:1403-1408.
14. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001, 357:1069-1075.
15. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
16. Altman D. Practical statistics for medical research. New York, NY: Chapman and Hall; 1991.
17. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
18. National Institutes of Health. Consensus Development Conference Panel statement. Management of hepatitis C. Hepatology 1997, 26 (3 Suppl. 1):2S-10S.
19. Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. The GERMED cyt-04 group. J Viral Hepat 2002, 9:128-133.
20. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986, 1:523-525.
21. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997, 349:825-832.
22. Guillen MI, Gomez-Lechon MJ, Nakamura T, Castell JV. The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6- stimulated genes. Hepatology 1996, 23:1345-1352.
23. Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, et al. TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 1999, 276:G1059-G1068.
24. Paradis V, Mathurin P, Ratziu V, Poynard T, Bedossa P. Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix. Hepatology 1996, 23: 1232-1238.
25. Kawser CA, Iredale JP, Winwood PJ, Arthur MJ. Rat hepatic stellate cell expression of alpha2-macroglobulin is a feature of cellular activation: implications for matrix remodelling in hepatic fibrosis. Clin Sci (Colch) 1998, 95:179-186.
26. Adams L, Rossi E, DeBoer B, Speers D, Macquillan G, Garas G, et al. Use of Fibrotest to predict liver fibrosis in hepatitis C: a replacement for liver biopsy? [Abstract]. Gastroenterology 2002, 122:159A.